Date | Title | Description | Source |
17.10.2012 | Tolera Therapeutics Closes $5.5M Series B-3 Financing | Tolera Therapeutics Inc., a Kalamazoo, Michigan-based biotechnology company focusing on the developm... | finsmes.co... |
11.01.2011 | Wound healing firm Celleration raises $8 million | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficient... | medcitynew... |
25.08.2010 | Northern Lights goes dim | Affinity Capital Management in Minneapolis and Cincinnati’s Triathlon Medical Ventures suspended the... | massdevice... |
18.08.2010 | Cancer drug developer Endocyte files for $86M IPO | Endocyte’s small-molecule drug conjugates “actively target receptors that are over-expressed on dise... | medcitynew... |
19.07.2010 | Mitralign wins $5 million credit line from GE Capital | GE Capital’s Healthcare Financial Services division gave Mitralign Inc. a $5 million line of credit.... | massdevice... |
21.06.2010 | Akebia Therapeutics aims at needs of chronic anemia patients | Pharmaceutical companies have developed injectable drugs, called erythropoietin-stimulating agents (... | medcitynew... |
10.06.2010 | Kereos aims to start first U.S. clinical trials in Q4 | Cited in 2004 as one of the industry’s top emerging biotechnology companies by FierceBiotech, Kereos... | medcitynew... |
07.06.2010 | Tolera Therapeutics gets $4M for organ transplant rejection ... | Tolera also plans to clinically investigate the drug’s ability to fight other autoimmune disorders, ... | medcitynew... |
11.05.2010 | Kereos raises $5.6M in equity for cancer drugs | Kereos hasn’t issued a press release since 2006 and lists in its “upcoming events” section a confere... | medcitynew... |
26.02.2010 | Cincinnati's Akebia starts Phase 1b clinical trial for anemi... | During the Phase 1b trial, three doses of AKB-6548 will be administered to about 33 healthy voluntee... | medcitynew... |
18.02.2010 | Affinity Capital and Triathlon Medical Ventures plan new $10... | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficient... | medcitynew... |
01.02.2010 | Ohio Third Frontier stakeholders hope for nearly full fundin... | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Hea... | medcitynew... |
16.10.2009 | Cancer drug business Endocyte raises $26 million | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis... | medcitynew... |
13.10.2009 | Cincinnati’s Akebia Therapeutics races (as safely as possibl... | Akebia is in a race to develop its drug against other treatments supported by the likes of GlaxoSmit... | medcitynew... |
31.07.2009 | The minds of Midwest VCs: Reform, commercialization czars an... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems st... | medcitynew... |
29.07.2009 | Cardiovascular biopharma Akebia takes additional funding to ... | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis... | medcitynew... |
09.07.2007 | BioVex raises $22M for cancer-killing viruses | Woburn, Mass.-based BioVex, a biotech working on new ways to attack cancer and infections, raised $2... | venturebea... |
- | Akebia Therapeutics aims at needs of chronic anemia patients | Being first isn’t the only goal in the drug-development business.
Sometimes, an unmet patient need ... | medcitynew... |
- | Cancer drug developer Endocyte files for $86M IPO | West Lafayette, Indiana, biopharmaceutical company Endocyte Inc. hopes to raise more than $86 millio... | medcitynew... |
- | Kereos raises $5.6M in equity for cancer drugs | Kereos Inc. has raised $5.6 million in equity to further develop cancer and cardiovascular-disease d... | medcitynew... |
- | Ohio Third Frontier stakeholders hope for nearly full fundin... | COLUMBUS, Ohio — Ask most people touched by Ohio Third Frontier whether the state’s largest economic... | medcitynew... |
- | Affinity Capital and Triathlon Medical Ventures plan new $10... | MINNEAPOLIS, Minnesota — Affinity Capital Management, a well-known local venture capital firm that i... | medcitynew... |
- | Cancer drug business Endocyte raises $26 million | WEST LAFAYETTE, Indiana — The cancer drug developer Endocyte has raised $26 million it will use to h... | medcitynew... |
- | Wound healing firm Celleration raises $8 million | Eden Prairie-based Celleration has raised $8 million in Series E stock toward more sales and marketi... | medcitynew... |
- | Cincinnati's Akebia starts Phase 1b clinical trial for anemi... | CINCINNATI, Ohio — Small molecule discovery and development company Akebia Therapeutics Inc. has sta... | medcitynew... |
- | Tolera Therapeutics gets $4M for organ transplant rejection ... | Cleveland Clinic spinoff Tolera Therapeutics Inc. has raised more than $4 million in equity to conti... | medcitynew... |
- | Kereos aims to start first U.S. clinical trials in Q4 | More than a decade after its founding, Kereos Inc. is planning in the fourth quarter to begin its fi... | medcitynew... |
- | The minds of Midwest VCs: Reform, commercialization czars an... | COLUMBUS, Ohio — Life-science entrepreneurs seem more concerned about the impact of health-care refo... | medcitynew... |
- | Cincinnati’s Akebia Therapeutics races (as safely as possibl... | CINCINNATI, Ohio — As Procter & Gamble started the slow dismantling of its pharmaceutical divisi... | medcitynew... |
- | Cardiovascular biopharma Akebia takes additional funding to ... | CINCINNATI, Ohio — Cardiovascular drugmaker Akebia Therapeutics will add $10 million more than expec... | medcitynew... |